The most cited article was published in 2010 and was titled “Improved Survival with Ipilimumab in Patients with Metastatic Melanoma (23).” The study reported the survival of patients with metastatic melanoma treated with ipilimumab plus gp100 and the probability and severity of irAEs. Here, PMEL is linked to melanoma.